Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1475 of 3173 entries
View as:

Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib

Phase: N/A Priority: Normal
NCT ID: NCT03220191 Org: User:
Start: 07/21/17 End: 09/26/17 Due: 09/26/18

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Phase: N/A Priority: Normal
NCT ID: NCT00037206 Org: User:
Start: 05/31/02 End: 02/28/03 Due: 02/28/04

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00992342 Org: User:
Start: 11/30/09 End: 03/31/10 Due: 03/31/11

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

Phase: N/A Priority: Normal
NCT ID: NCT04115189 Org: User:
Start: 12/13/19 End: 12/02/20 Due: 12/02/21

Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

Phase: N/A Priority: Normal
NCT ID: NCT00800280 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05096208 Org: User:
Start: 10/21/21 End: 04/04/22 Due: 04/04/23

Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01655511 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01933672 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

LGX818 for Patients With BRAFV600 Mutated Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01981187 Org: User:
Start: 01/14/14 End: 10/13/15 Due: 10/13/16

A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

Phase: N/A Priority: Normal
NCT ID: NCT02580058 Org: User:
Start: 12/21/15 End: 07/12/22 Due: 07/12/23

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01547299 Org: User:
Start: 03/31/12 End: 11/30/13 Due: 11/30/14

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05652660 Org: User:
Start: 12/09/22 End: 03/06/23 Due: 03/06/24

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00847613 Org: User:
Start: 03/31/09 End: 02/29/12 Due: 02/28/13

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Phase: N/A Priority: Normal
NCT ID: NCT04446039 Org: User:
Start: 07/04/22 End: 11/03/22 Due: 11/03/23

A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days

Phase: N/A Priority: Normal
NCT ID: NCT01234142 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different Formulations

Phase: N/A Priority: Normal
NCT ID: NCT03765554 Org: User:
Start: 01/07/19 End: 04/03/19 Due: 04/03/20

Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

Phase: N/A Priority: Normal
NCT ID: NCT00174460 Org: User:
Start: 08/31/05 End: 03/31/10 Due: 03/31/11

Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos

Phase: N/A Priority: Normal
NCT ID: NCT01396434 Org: User:
Start: 12/31/11 End: 05/31/14 Due: 05/31/15

Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma

Phase: N/A Priority: Normal
NCT ID: NCT01395420 Org: User:
Start: 08/31/11 End: 07/31/12 Due: 07/31/13

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

Phase: N/A Priority: Normal
NCT ID: NCT05375942 Org: User:
Start: 11/11/22 End: 11/11/22 Due: 11/11/23

Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT01430559 Org: User:
Start: 10/24/11 End: 03/27/13 Due: 03/27/14

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01414257 Org: User:
Start: 05/31/11 End: 03/31/14 Due: 03/31/15

To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

Phase: N/A Priority: Normal
NCT ID: NCT00143104 Org: User:
Start: 12/31/04 End: 10/31/06 Due: 10/31/07

Trial in Adult Subjects With Acute Migraines

Phase: N/A Priority: Normal
NCT ID: NCT03461757 Org: User:
Start: 02/27/18 End: 10/15/18 Due: 10/15/19

Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

Phase: N/A Priority: Normal
NCT ID: NCT05155566 Org: User:
Start: 05/15/19 End: 03/12/21 Due: 03/12/22